Noteworthy, an increased expression of GRP78 and members of UPR, which activate the pro-inflammatory cytokine TNF-α [35,36] that is directly implicated in the pathogenesis of IBD, can be reversed by RCME proposing this mixture to be considered in IBD therapies. This evidence concerns the gene HSPA5 and inflammatory bowel disease.